Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Gains from Investment Securities (2017 - 2024)

Historic Gains from Investment Securities for Selectis Health (GBCS) over the last 11 years, with Q2 2024 value amounting to $2.1 million.

  • Selectis Health's Gains from Investment Securities changed N/A to $2.1 million in Q2 2024 from the same period last year, while for Dec 2024 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2024, which is N/A changed from last year.
  • Per Selectis Health's latest filing, its Gains from Investment Securities stood at $2.1 million for Q2 2024.
  • Over the past 5 years, Selectis Health's Gains from Investment Securities peaked at $2.1 million during Q2 2024, and registered a low of $60000.0 during Q4 2021.
  • In the last 4 years, Selectis Health's Gains from Investment Securities had a median value of $238406.5 in 2020 and averaged $551492.7.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 575415.05% in 2020, then plummeted by 7784.45% in 2021.
  • Selectis Health's Gains from Investment Securities (Quarter) stood at $270813.0 in 2020, then crashed by 77.84% to $60000.0 in 2021, then changed by 0.0% to $60000.0 in 2022, then skyrocketed by 3420.24% to $2.1 million in 2024.
  • Its last three reported values are $2.1 million in Q2 2024, $60000.0 for Q4 2022, and $206000.0 during Q2 2022.